GSK3B and Alzheimer disease: We observed that truncation of GSK-3β was correlated with activation of calpain I strongly and positively (r = 0.9297, p < 0.0001) (Fig. 1E), suggesting that overactivation of calpain I might have led to GSK-3β truncation in AD brain.